Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program

Hiroshi Matsuo; Martin Prins; Anthonie W. A. Lensing; Emi Watanabe Fujinuma; Yuki Miyamoto; Mariko Kajikawa

doi:10.1185/03007995.2015.1037728

Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program

Hiroshi Matsuo^*, Martin Prins, Anthonie W. A. Lensing, Emi Watanabe Fujinuma, Yuki Miyamoto, Mariko Kajikawa

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1057-1061
Journal	Current Medical Research and Opinion
Volume	31
Issue number	6
DOIs	https://doi.org/10.1185/03007995.2015.1037728
Publication status	Published - Jun 2015

Keywords

Deep vein thrombosis
Japan
Length of stay
Pulmonary embolism
Randomized trial
Rivaroxaban
Unfractionated heparin
Venous thromboembolism
Warfarin

Access to Document

10.1185/03007995.2015.1037728

Cite this

Matsuo, H., Prins, M., Lensing, A. W. A., Fujinuma, E. W., Miyamoto, Y., & Kajikawa, M. (2015). Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program. Current Medical Research and Opinion, 31(6), 1057-1061. https://doi.org/10.1185/03007995.2015.1037728

Matsuo, Hiroshi ; Prins, Martin ; Lensing, Anthonie W. A. ; Fujinuma, Emi Watanabe ; Miyamoto, Yuki ; Kajikawa, Mariko. / Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program. In: Current Medical Research and Opinion. 2015 ; Vol. 31, No. 6. pp. 1057-1061.

@article{3724dda90a794969b241f47ae5e98174,

title = "Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program",

keywords = "Deep vein thrombosis, Japan, Length of stay, Pulmonary embolism, Randomized trial, Rivaroxaban, Unfractionated heparin, Venous thromboembolism, Warfarin",

author = "Hiroshi Matsuo and Martin Prins and Lensing, {Anthonie W. A.} and Fujinuma, {Emi Watanabe} and Yuki Miyamoto and Mariko Kajikawa",

year = "2015",

month = jun,

doi = "10.1185/03007995.2015.1037728",

language = "English",

volume = "31",

pages = "1057--1061",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",

publisher = "Routledge/Taylor & Francis Group",

number = "6",

}

Matsuo, H, Prins, M, Lensing, AWA, Fujinuma, EW, Miyamoto, Y & Kajikawa, M 2015, 'Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program', Current Medical Research and Opinion, vol. 31, no. 6, pp. 1057-1061. https://doi.org/10.1185/03007995.2015.1037728

Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program. / Matsuo, Hiroshi; Prins, Martin; Lensing, Anthonie W. A.; Fujinuma, Emi Watanabe; Miyamoto, Yuki; Kajikawa, Mariko.

In: Current Medical Research and Opinion, Vol. 31, No. 6, 06.2015, p. 1057-1061.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program

AU - Matsuo, Hiroshi

AU - Prins, Martin

AU - Lensing, Anthonie W. A.

AU - Fujinuma, Emi Watanabe

AU - Miyamoto, Yuki

AU - Kajikawa, Mariko

PY - 2015/6

Y1 - 2015/6

KW - Deep vein thrombosis

KW - Japan

KW - Length of stay

KW - Pulmonary embolism

KW - Randomized trial

KW - Rivaroxaban

KW - Unfractionated heparin

KW - Venous thromboembolism

KW - Warfarin

U2 - 10.1185/03007995.2015.1037728

DO - 10.1185/03007995.2015.1037728

M3 - Article

C2 - 25851062

VL - 31

SP - 1057

EP - 1061

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 6

ER -